Trending
More/production/238778/large-1370875291.png)
DelMarPharma
DelMar Pharma
Del Mar Pharma is developing new drug candidates targeting orphan cancer indications. VAL-083 is in clinical trials for glioblastoma multiforme. (OTCQB: DMPI)
Strategy:
Vancouver and Menlo Park http://www.delmarpharma.com
Joined 6/2013- Posts
- Posts & Replies
- Liked
- 0 Watchlist
- Portfolio